Follow
Peter Calabresi
Peter Calabresi
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
39512014
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
L Kappos, EW Radue, P O'Connor, C Polman, R Hohlfeld, P Calabresi, ...
New England Journal of Medicine 362 (5), 387-401, 2010
32922010
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ...
New England Journal of Medicine 354 (9), 911-923, 2006
17272006
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification
K Hua, J Zhang, S Wakana, H Jiang, X Li, DS Reich, PA Calabresi, ...
Neuroimage 39 (1), 336-347, 2008
15822008
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial
K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ...
Annals of neurology 66 (4), 460-471, 2009
10812009
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
9892019
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
9562011
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
PA Calabresi, EW Radue, D Goodin, D Jeffery, KW Rammohan, AT Reder, ...
The Lancet Neurology 13 (6), 545-556, 2014
9382014
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
JB Fisher, DA Jacobs, CE Markowitz, SL Galetta, NJ Volpe, ...
Ophthalmology 113 (2), 324-332, 2006
8752006
Saccade preparation inhibits reorienting to recently attended locations.
RD Rafal, PA Calabresi, CW Brennan, TK Sciolto
Journal of Experimental Psychology: Human perception and performance 15 (4), 673, 1989
7221989
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
A Petzold, JF de Boer, S Schippling, P Vermersch, R Kardon, A Green, ...
The Lancet Neurology 9 (9), 921-932, 2010
7172010
Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases
C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, ...
Proceedings of the National Academy of Sciences 103 (46), 17414-17419, 2006
6142006
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ...
Annals of neurology 67 (4), 452-461, 2010
6102010
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
6102008
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled …
L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ...
Nature medicine 6 (10), 1176-1182, 2000
6102000
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
SS Soldan, R Berti, N Salem, P Secchiero, L Flamand, PA Calabresi, ...
Nature medicine 3 (12), 1394-1397, 1997
5871997
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
MD Kornberg, P Bhargava, PM Kim, V Putluri, AM Snowman, N Putluri, ...
Science 360 (6387), 449-453, 2018
5852018
The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
H Wulff, PA Calabresi, R Allie, S Yun, M Pennington, C Beeton, ...
The Journal of clinical investigation 111 (11), 1703-1713, 2003
5562003
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
5322017
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E Gordon-Lipkin, B Chodkowski, DS Reich, SA Smith, M Pulicken, ...
Neurology 69 (16), 1603-1609, 2007
5132007
The system can't perform the operation now. Try again later.
Articles 1–20